
Raflozon TZ 1000mg/125mg Injection
Marketer
Raviolis Healthcare
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Raflozon TZ 1000mg/125mg Injection
Cephalosporin-based injection, Raflozon TZ (1000mg/125mg), combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under medical supervision; complete the prescribed dosage regardless of symptom improvement to ensure efficacy. Premature cessation can compromise treatment. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea, indigestion). Severe reactions necessitate immediate medical attention; allergic symptoms (rash, itching, swelling, respiratory distress) require prompt emergency care. Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving, avoid operating vehicles if experiencing dizziness or somnolence. Adequate rest, balanced nutrition, and hydration promote recovery. Monitoring may involve blood tests to assess treatment response.
Primary Ingredients of Raflozon TZ 1000mg/125mg Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Raflozon TZ 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Raflozon TZ 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Raflozon TZ 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Raflozon TZ 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Raflozon TZ 1000mg/125mg Injection works:
Ceftriaxone/Tazobactam 1000mg/125mg (Raflozon TZ) injection combines a cephalosporin antibiotic (ceftriaxone) with a beta-lactamase inhibitor (tazobactam). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their growth. Tazobactam counteracts bacterial resistance mechanisms, optimizing ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Raflozon TZ 1000mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Raflozon TZ 1000mg/125mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Raflozon TZ 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended until the maternal course of treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administration of Raflozon TZ 1000mg/125mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Raflozon TZ 1000mg/125mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Raflozon TZ 1000mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration of Raflozon TZ 1000mg/125mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Raflozon TZ 1000mg/125mg Injection :
Omit a Raflozon TZ 1000mg/125mg Injection dose? Seek your physician's advice.
Facts to Know About Raflozon TZ 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
